Evaluating late pregnancy preeclampsia risk requires understanding both placental health and maternal vascular responses. Clinicians currently rely on uterine artery Doppler in early gestation to assess placental perfusion. However, its exact mechanism in third-trimester screening has remained uncertain until recently. Furthermore, a major observational study highlights how late-gestation Doppler findings correlate with key cardiovascular and angiogenic pathways.
Angiogenic Mechanisms in Late Pregnancy Preeclampsia
Placental angiogenic imbalance drives most of the association between Doppler findings and late-stage complications. Specifically, placental growth factor mediates approximately 40% of this clinical relationship. Furthermore, soluble fms-like tyrosine kinase-1 contributes another 9% to the total effect. Consequently, lower angiogenic factor levels strongly signal an elevated risk of clinical preeclampsia.
Hemodynamic and Vascular Contributions
Maternal hemodynamic adaptation also plays a meaningful role in disease development. For instance, the ophthalmic artery peak systolic velocity ratio mediates around 15% of the Doppler association. However, arterial stiffness measured by pulse wave velocity does not show a direct mediating effect. Therefore, cerebral maternal hemodynamics offer distinct diagnostic value beyond simple vascular stiffness.
Clinical Implications for Obstetric Practice
Multivariable models show that uterine artery Doppler loses independent predictive power when angiogenic and hemodynamic markers enter the equation. As a result, elevated angiogenic ratios and abnormal ophthalmic artery Doppler findings independently signal increased preeclampsia risk. Meanwhile, higher placental growth factor provides a powerful protective signature for late-gestation management. Thus, clinicians should integrate biomarker panels with Doppler indices to refine risk assessment in late pregnancy.
Frequently Asked Questions
Q1: What does uterine artery Doppler reflect at 35-36 weeks of gestation?
It primarily reflects underlying placental angiogenic imbalance and maternal cerebral hemodynamic resistance rather than isolated uterine vascular resistance.
Q2: How do PlGF and sFlt-1 influence preeclampsia risk in late pregnancy?
Higher PlGF levels offer significant protection against preeclampsia. Conversely, higher sFlt-1 levels strongly correlate with an increased risk of developing the condition.
Q3: Should uterine artery Doppler be used alone for late-pregnancy screening?
No, because Doppler findings lose independent predictive significance when clinicians evaluate them alongside angiogenic biomarkers and maternal hemodynamic parameters.
References
- Chatzakis C et al. What does uterine artery Doppler reflect in late pregnancy? Insights from angiogenic, hemodynamic, and vascular markers in preeclampsia. Am J Obstet Gynecol. 2026 Aug 07. doi: undefined. PMID: 42567393.
- Papageorghiou AT, Yu CK, Nicolaides KH. The role of uterine artery Doppler in predicting adverse pregnancy outcome. Best Pract Res Clin Obstet Gynaecol. 2004;18(3):383-396.
- Zeisler H, Llurba E, Chantraine F, et al. Predictive value of the sFlt-1:PlGF ratio in women with suspected preeclampsia. N Engl J Med. 2016;374(1):13-22.